SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-008662
Filing Date
2023-03-17
Accepted
2023-03-17 17:17:55
Documents
13
Period of Report
2023-03-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K celu-20230314.htm   iXBRL 8-K 56623
  Complete submission text file 0000950170-23-008662.txt   212016

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20230314.xsd EX-101.SCH 3461
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20230314_pre.xml EX-101.PRE 14184
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20230314_def.xml EX-101.DEF 14174
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20230314_lab.xml EX-101.LAB 17766
7 EXTRACTED XBRL INSTANCE DOCUMENT celu-20230314_htm.xml XML 6500
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 23743840
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences